These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 17107970

  • 21. Protection of oral or intestinal candidiasis in mice by oral or intragastric administration of herbal food, clove (Syzygium aromaticum).
    Taguchi Y, Ishibashi H, Takizawa T, Inoue S, Yamaguchi H, Abe S.
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(1):27-33. PubMed ID: 15711533
    [Abstract] [Full Text] [Related]

  • 22. An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.
    Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, Akova M, Cohen J, Siffnerová H, Egyed M, Ellis M, Marinus A, Sylvester R, Kullberg BJ, EORTC Invasive Fungal Infections Group.
    Eur J Cancer; 2004 Jun; 40(9):1314-9. PubMed ID: 15177489
    [Abstract] [Full Text] [Related]

  • 23. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY).
    Ibrahim el-SM, Rahman AK, Isoda R, Umeda K, Van Sa N, Kodama Y.
    Vaccine; 2008 Apr 16; 26(17):2073-80. PubMed ID: 18375022
    [Abstract] [Full Text] [Related]

  • 24. Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis.
    Groll AH, Wood L, Roden M, Mickiene D, Chiou CC, Townley E, Dad L, Piscitelli SC, Walsh TJ.
    Antimicrob Agents Chemother; 2002 Aug 16; 46(8):2554-63. PubMed ID: 12121932
    [Abstract] [Full Text] [Related]

  • 25. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR, Vazquez J, Darouiche RO, Morhart R, Greenspan D, Tuazon C, Wheat LJ, Carey J, Leviton I, Hewitt RG, MacGregor RR, Valenti W, Restrepo M, Moskovitz BL.
    Am J Med; 1998 Jan 16; 104(1):33-9. PubMed ID: 9528717
    [Abstract] [Full Text] [Related]

  • 26. Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules.
    Cross LJ, Bagg J, Oliver D, Warnock D.
    J Antimicrob Chemother; 2000 Jan 16; 45(1):95-9. PubMed ID: 10629018
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
    Mouton JW, van Peer A, de Beule K, Van Vliet A, Donnelly JP, Soons PA.
    Antimicrob Agents Chemother; 2006 Dec 16; 50(12):4096-102. PubMed ID: 16982783
    [Abstract] [Full Text] [Related]

  • 28. Protection of immunosuppressed mice from lethal Candida infection by oral administration of a kampo medicine, hochu-ekki-to.
    Abe S, Tansho S, Ishibashi H, Akagawa G, Komatsu Y, Yamaguchi H.
    Immunopharmacol Immunotoxicol; 1999 May 16; 21(2):331-42. PubMed ID: 10319284
    [Abstract] [Full Text] [Related]

  • 29. Studies on itraconazole delivery and pharmacokinetics in mallard ducks (Anas platyrhynchos).
    Tell LA, Craigmill AL, Clemons KV, Sun Y, Laizure SC, Clifford A, Ina JH, Nugent-Deal JP, Woods L, Stevens DA.
    J Vet Pharmacol Ther; 2005 Jun 16; 28(3):267-74. PubMed ID: 15953200
    [Abstract] [Full Text] [Related]

  • 30. [Microbiological efficacy of a one-day treatment with triazole antimycotic I traconazole in mycotic colpitis].
    Andreeva P, Savova D, Konovalova M, Unakova M, Shterev A.
    Akush Ginekol (Sofiia); 2014 Jun 16; 53(7):9-12. PubMed ID: 25675616
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA, Kim HG, Long L.
    J Antimicrob Chemother; 2007 Mar 16; 59(3):556-9. PubMed ID: 17242032
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation.
    Michallet M, Persat F, Kranzhöfer N, Levron JC, Prat C, Belhabri A, Chwetzoff E, Le Moing JP, Fiere D, Piens MA.
    Bone Marrow Transplant; 1998 Jun 16; 21(12):1239-43. PubMed ID: 9674858
    [Abstract] [Full Text] [Related]

  • 33. In vivo distribution and therapeutic efficacy of a novel amphotericin B poly-aggregated formulation.
    Espada R, Valdespina S, Dea MA, Molero G, Ballesteros MP, Bolás F, Torrado JJ.
    J Antimicrob Chemother; 2008 May 16; 61(5):1125-31. PubMed ID: 18285313
    [Abstract] [Full Text] [Related]

  • 34. Successful treatment using peroral itraconazole in a patient with acute promyelocytic leukemia complicated with splenic candidiasis.
    Kumura T, Hino M, Nakao T, Yamane T, Ohta K, Wakasa K, Takubo T, Tatsumi N.
    Osaka City Med J; 1999 Jun 16; 45(1):9-13. PubMed ID: 10723197
    [Abstract] [Full Text] [Related]

  • 35. Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis.
    Sugar AM, Liu XP.
    J Infect Dis; 1998 Jun 16; 177(6):1660-3. PubMed ID: 9607846
    [Abstract] [Full Text] [Related]

  • 36. European experience with oral solution and intravenous itraconazole.
    Potter M.
    Oncology (Williston Park); 2001 Nov 16; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.
    Reynes J, Bazin C, Ajana F, Datry A, Le Moing JP, Chwetzoff E, Levron JC.
    Antimicrob Agents Chemother; 1997 Nov 16; 41(11):2554-8. PubMed ID: 9371367
    [Abstract] [Full Text] [Related]

  • 38. Approval for itraconazole oral solution.
    AIDS Patient Care STDS; 1997 Oct 16; 11(5):377. PubMed ID: 11361829
    [No Abstract] [Full Text] [Related]

  • 39. [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)].
    Otani H, Inoue K, Shiota T, Suzuki Y, Nomura S, Harada Y, Ishibashi H, Abe S, Uchida K, Yamaguchi H, Torii S.
    Nihon Yakurigaku Zasshi; 2007 Jul 16; 130(1):69-76. PubMed ID: 17634684
    [No Abstract] [Full Text] [Related]

  • 40. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U, Willers C, Bubenheim M, Horstkotte MA, Houdek P, Fischer F, Schmage P, Moll I, Brandner JM.
    Mycoses; 2008 Jan 16; 51(1):21-9. PubMed ID: 18076591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.